Skip to Main Content

Advertisement

American Association of Immunologists Journals
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 12
1 December 2020
ImmunoHorizons Cover Image for Volume 4, Issue 12
EISSN 2573-7732

Adaptive Immunity

A Novel Outbred Mouse Model to Study Lung Memory Immunological Response Induced by Pertussis Vaccines
Nicolas Rouleau; Emilie Proust; Martine Chabaud-Riou
Immunohorizons (2020) 4 (12): 762–773.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for A Novel Outbred Mouse Model to Study Lung Memory Immunological Response Induced by Pertussis Vaccines
Mass Cytometry Defines Virus-Specific CD4+ T Cells in Influenza Vaccination
Priyanka B. Subrahmanyam; Tyson H. Holmes; Dongxia Lin; Laura F. Su; Gerlinde Obermoser; Jacques Banchereau; Virginia Pascual; Adolfo García-Sastre; Randy A. Albrecht; Karolina Palucka; Mark M. Davis; Holden T. Maecker
Immunohorizons (2020) 4 (12): 774–788.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for Mass Cytometry Defines Virus-Specific CD4<sup>+</sup> T Cells in Influenza Vaccination
Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells
Sunnie Hsiung; Alejandro Moro; Yuguang Ban; Xi Chen; Alicia Santos Savio; Rosmely Hernandez; Thomas R. Malek
Immunohorizons (2020) 4 (12): 809–824.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells

Innate Immunity

RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis
R. K. Subbarao Malireddi; Sannula Kesavardhana; Rajendra Karki; Balabhaskararao Kancharana; Amanda R. Burton; Thirumala-Devi Kanneganti
Immunohorizons (2020) 4 (12): 789–796.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for RIPK1 Distinctly Regulates <em>Yersinia</em>-Induced Inflammatory Cell Death, PANoptosis
Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice
Irene Lau; Carolina de Amat Herbozo; Meggie Kuypers; Qiaochu Lin; Christophe Paget; Thierry Mallevaey
Immunohorizons (2020) 4 (12): 797–808.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice
Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2
Madelyn H. Miller; Michael G. Shehat; Justine T. Tigno-Aranjuez
Immunohorizons (2020) 4 (12): 825–836.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2

Clinical and Translational Immunology

Enhanced Immunotherapeutic Efficacy of Anti–PD-L1 Antibody in Combination with an EP4 Antagonist
Yamato Sajiki; Satoru Konnai; Zimeng Cai; Kensuke Takada; Tomohiro Okagawa; Naoya Maekawa; Sotaro Fujisawa; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Immunohorizons (2020) 4 (12): 837–850.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Add to Citation Manager for Enhanced Immunotherapeutic Efficacy of Anti–PD-L1 Antibody in Combination with an EP4 Antagonist
All Issues

Advertisement

Advertisement

Advertisement

  • Online ISSN 2573-7732

Publications

Submit a Manuscript

General Information

Journal Services

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept